| Authors | Ulrich Dührsen, Mareike Tometten, Frank Kroschinsky, Arnold Ganser, Stefan Ibach, Stefanie Bertram, Andreas Hüttmann |
| Journal | Blood cancer journal
(Blood Cancer J)
Vol. 11
Issue 5
Pg. 95
(05 17 2021)
ISSN: 2044-5385 [Electronic] United States |
| PMID | 34001867
(Publication Type: Clinical Trial, Phase I, Clinical Trial, Phase II, Letter, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Cytarabine
- Rituximab
- Lenalidomide
- Leucovorin
- Methotrexate
|
| Topics |
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Cytarabine
(adverse effects, therapeutic use)
- Female
- Humans
- Lenalidomide
(adverse effects, therapeutic use)
- Leucovorin
(adverse effects, therapeutic use)
- Lymphoma, Large B-Cell, Diffuse
(drug therapy)
- Male
- Methotrexate
(adverse effects, therapeutic use)
- Middle Aged
- Neoplasm Recurrence, Local
(drug therapy)
- Rituximab
(adverse effects, therapeutic use)
- Survival Analysis
|
